BioLine RX (Israel) Price on November 21, 2024
| BLRX Stock | ILS 8.10 0.10 1.25% |
If you're considering investing in BioLine Stock, it is important to understand the factors that can impact its price. As of today, the current price of BioLine RX stands at 8.10, as last reported on the 30th of November, with the highest price reaching 8.50 and the lowest price hitting 7.80 during the day. BioLine RX secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23% return per unit of risk over the last 3 months. BioLine RX exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLine RX's Standard Deviation of 5.94, risk adjusted performance of (0.13), and Mean Deviation of 3.58 to double-check the risk estimate we provide.
BioLine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
BioLine |
Sharpe Ratio = -0.234
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BLRX |
Estimated Market Risk
| 6.03 actual daily | 53 53% of assets are less volatile |
Expected Return
| -1.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioLine RX is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioLine RX by adding BioLine RX to a well-diversified portfolio.
BioLine RX Valuation on November 21, 2024
It is possible to determine the worth of BioLine RX on a given historical date. On November 21, 2024 BioLine was worth 12.6 at the beginning of the trading date compared to the closed value of 10.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioLine RX stock. Still, in general, we apply an absolute valuation method to find BioLine RX's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioLine RX where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioLine RX's related companies.
| Open | High | Low | Close | Volume | |
| 13.30 | 14.20 | 13.30 | 14.00 | 2,775,222 | |
11/21/2024 | 12.60 | 12.70 | 10.00 | 10.50 | 13,837,079 |
| 8.90 | 9.80 | 7.20 | 7.80 | 21,980,182 |
| Backtest BioLine RX | | | BioLine RX History | | | BioLine RX Valuation | Previous | Next |
BioLine RX Trading Date Momentum on November 21, 2024
| On November 25 2024 BioLine RX was traded for 7.80 at the closing time. The highest price during the trading period was 9.80 and the lowest recorded bid was listed for 7.20 . The volume for the day was 22 M. This history from November 25, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 25.71% . The overall trading delta to the current price is 20.00% . |
BioLine RX Fundamentals Correlations and Trends
By evaluating BioLine RX's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioLine RX's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioLine financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioLine RX Stock history
BioLine RX investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioLine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioLine RX will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioLine RX stock prices may prove useful in developing a viable investing in BioLine RX
BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology. BioLineRx Ltd. was founded in 2003 and is based in Modiin, Israel. BIOLINE RX operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 48 people.
BioLine RX Stock Technical Analysis
BioLine RX technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioLine RX Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
BioLine RX cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BioLine RX November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how BioLine RX stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioLine RX shares will generate the highest return on investment. By undertsting and applying BioLine RX stock market strength indicators, traders can identify BioLine RX entry and exit signals to maximize returns
BioLine RX Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioLine RX's price direction in advance. Along with the technical and fundamental analysis of BioLine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioLine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.02) | |||
| Total Risk Alpha | (2.09) | |||
| Treynor Ratio | 1.74 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BioLine Stock analysis
When running BioLine RX's price analysis, check to measure BioLine RX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLine RX is operating at the current time. Most of BioLine RX's value examination focuses on studying past and present price action to predict the probability of BioLine RX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLine RX's price. Additionally, you may evaluate how the addition of BioLine RX to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |